| pubmed-article:1920351 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1920351 | lifeskim:mentions | umls-concept:C0034792 | lld:lifeskim |
| pubmed-article:1920351 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:1920351 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:1920351 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
| pubmed-article:1920351 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:1920351 | pubmed:dateCreated | 1991-11-18 | lld:pubmed |
| pubmed-article:1920351 | pubmed:abstractText | Seven analogues of 3-quinuclidinyl benzilate (QNB) in which one phenyl ring was replaced by an alkoxyalkyl moiety were synthesized and their affinities for the muscarinic cholinergic receptor determined. An oxygen in the beta-position of the moiety was not well-tolerated. By contrast, an oxygen in the gamma-position did not change the affinity for the muscarinic receptor. However, when a bromine was placed on the remaining phenyl ring, the affinity was significantly reduced in striking contrast to results obtained on halogenation of QNB. | lld:pubmed |
| pubmed-article:1920351 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1920351 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1920351 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1920351 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1920351 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:1920351 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:GibsonR ERE | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:RebaR CRC | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:CohenV IVI | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:JanH HHH | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:GitlerM SMS | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:HarimanEE | lld:pubmed |
| pubmed-article:1920351 | pubmed:author | pubmed-author:De La CruzRR | lld:pubmed |
| pubmed-article:1920351 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1920351 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:1920351 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1920351 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1920351 | pubmed:pagination | 2989-93 | lld:pubmed |
| pubmed-article:1920351 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:meshHeading | pubmed-meshheading:1920351-... | lld:pubmed |
| pubmed-article:1920351 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1920351 | pubmed:articleTitle | Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetates. | lld:pubmed |
| pubmed-article:1920351 | pubmed:affiliation | Section of Radiopharmaceutical Chemistry, George Washington University Medical Center, Washington, D.C. 20037. | lld:pubmed |
| pubmed-article:1920351 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1920351 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1920351 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1920351 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:1920351 | lld:chembl |
